Literature DB >> 12416743

Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.

Toru Takahashi, Eiichi Oeda, Yutaka Sato, Yukio Tanizawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416743     DOI: 10.1007/bf02982802

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

Review 1.  Epstein-Barr virus--associated diseases in humans.

Authors:  K Kawa
Journal:  Int J Hematol       Date:  2000-02       Impact factor: 2.490

2.  Ganciclovir for chronic active Epstein-Barr virus infection.

Authors:  Y Ishida; Y Yokota; H Tauchi; M Fukuda; T Takaoka; M Hayashi; H Matsuda
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

3.  Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection.

Authors:  H Kimura; K Nishikawa; Y Hoshino; A Sofue; Y Nishiyama; T Morishima
Journal:  Med Microbiol Immunol       Date:  2000-06       Impact factor: 3.402

4.  Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus.

Authors:  E C Mar; C K Chu; J C Lin
Journal:  Antiviral Res       Date:  1995-09       Impact factor: 5.970

5.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

  5 in total
  1 in total

1.  Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Authors:  Christos Stefanou; Christiana Tzortzi; Fotini Georgiou; Chrystalla Timiliotou
Journal:  BMJ Case Rep       Date:  2016-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.